Increased sensitivity of serotonin on the voltage-dependent K+ channels in mesenteric arterial smooth muscle cells of OLETF rats

Progress in Biophysics and Molecular Biology

Volumn 103, Issue 1, 2010, Pages 88-94

  Ko, Eun A ^a   Park, Won Sun ^b   Firth, Amy L ^c   Hong, Da Hae ^a   Choi, Seong Woo ^a   Heo, Hye Jin ^a   Kim, Min Hee ^a   Noh, Jung Hyun ^a,d   Ko, Jae Hong ^e   Kim, Nari ^a   Earm, Yung E ^f   Song, Dae Kyu ^f   Han, Jin ^a  

^a Inje University College of Medicine   (South Korea)

^b Kangwon National University   (South Korea)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^d Inje University College of Medicine   (South Korea)

^e Chung Ang University College of Medicine   (South Korea)

^f Keimyung University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

RATTUS;

EID: 77955267665     PISSN: 00796107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbiomolbio.2010.02.003     Document Type: Review

References (25)

1. + currents. Biochem. Biophys. Res. Commun. 2006, 347:468-476.
2. Banes A.K., Watts S.W. Upregulation of arterial serotonin 1B and 2B receptors in deoxycorticosterone acetate-salt hypertension. Hypertension 2002, 39:394-398.
3. + channels and pulmonary vasoconstriction: role of protein kinase Czeta. Circ. Res. 2003, 93:656-663.
4. Creager M.A., Lüscher T.F., Cosentino F., Beckman J.A. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circulation 2003, 108:1527-1532.
5. + channels of rat arterial smooth muscle. Am. J. Physiol. Heart Circ. Physiol. 2001, 281:H2480-H2489.
6. Huang Q., Bu S., Yu Y., Guo Z., Ghatnekar G., Bu M., Yang L., Lu B., Feng Z., Liu S., Wang F. Diazoxide prevents diabetes through inhibiting pancreatic beta-cells from apoptosis via Bcl-2/Bax rate and p38-beta mitogen-activated protein kinase. Endocrinology 2007, 148:81-91.
7. Inoguchi T., Battan R., Handler E., Sportsman J.R., Heath W., King G.L. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc. Natl. Acad. Sci. U S A 1992, 89:11059-11063.
8. Ishii H., Jirousek M.R., Koya D., Takagi C., Xia P., Clermont A., Bursell S.E., Kern T.S., Ballas L.M., Heath W.F., Stramm L.E., Feener E.P., King G.L. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 1996, 272:728-731.
9. Jesmin S., Sakuma I., Hattori Y., Fujii S., Kitabatake A. Long-acting calcium channel blocker benidipine suppresses expression of angiogenic growth factors and prevents cardiac remodelling in a type II diabetic rat model. Diabetologia 2002, 45:402-415.
10. Ko E.A., Amiri F., Pandey N.R., Javeshghani D., Leibovitz E., Touyz R.M., Schiffrin E.L. Resistance artery remodeling in deoxycorticosterone acetate-salt hypertension is dependent on vascular inflammation: evidence from m-CSF-deficient mice. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H1789-H1795.
11. Lüscher T.F., Creager M.A., Beckman J.A., Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Circulation 2003, 108:1655-1661.
12. Martiny-Baron G., Kazanietz M.G., Mischak H., Blumberg P.M., Kochs G., Hug H., Marmé D., Schächtele C. Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. J. Biol. Chem. 1993, 268:9194-9197.
13. + channel blockade in mesenteric arterial smooth muscle and intestinal epithelial cells. J. Appl. Physiol. 2001, 91:2322-2333.
14. McGregor D.D., Smirk F.H. Vascular responses to 5-hydroxytryptamine in genetic and renal hypertensive rats. Am. J. Physiol. 1970, 219:687-690.
15. Rainbow R.D., Hardy M.E., Standen N.B., Davies N.W. Glucose reduces endothelin inhibition of voltage-gated potassium channels in rat arterial smooth muscle cells. J. Physiol. 2006, 575:833-844.
16. + channels through different protein kinase C isoenzymes. Cardiovasc. Res. 2009, 83:493-500.
17. Rosón M.I., Maquieira M.K., de la Riva I.J. Contrasting effects of norepinephrine and 5-hydroxytryptamine on contractility of abdominal aorta of two kidney-two clip hypertensive rats. Effects of inhibitors of arachidonic acid metabolic enzymes. Clin. Exp. Hypertens. A. 1990, 12:285-306.
18. Saito F., Kawaguchi M., Izumida J., Asakura T., Maehara K., Maruyama Y. Alteration in haemodynamics and pathological changes in the cardiovascular system during the development of type 2 diabetes mellitus in OLETF rats. Diabetologia 2003, 46:1161-1169.
19. Shiba T., Inoguchi T., Sportsman J.R., Heath W.F., Bursell S., King G.L. Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am. J. Physiol. 1993, 265:E783-E793.
20. Thompson L.P., Webb R.C. Vascular responsiveness to serotonin metabolites in mineralocorticoid hypertension. Hypertension 1987, 9:277-281.
21. Vanhoutte P., Amery A., Birkenhager W., Breckenridge A., Buhler F., Distler A., Dormandy J., Doyle A., Frohlich E., Hansson L., Hedner T., Hollenberg N., Jensen H.-E., Lund-Johansen P., Meyer P., Opie L., Robertson I., Safar M., Schalekamp M., Symoens J., Trap-Jensen J., Zanchetti A. Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin. Hypertension 1988, 11:111-133.
22. Watts S.W., Fink G.D. 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats. Am. J. Physiol. 1999, 276:H944-H952.
23. Watts S.W., Gilbert L., Webb R.C. 5-Hydroxytryptamine2B receptor mediates contraction in the mesenteric artery of mineralocorticoid hypertensive rats. Hypertension 1995, 26:1056-1059.
24. Watts S.W., Baez M., Webb R.C. The 5-hydroxytryptamine2B receptor and 5-HT receptor signal transduction in mesenteric arteries from deoxycorticosterone acetate-salt hypertensive rats. J. Pharmacol. Exp. Ther. 1996, 277:1103-1113.
25. Watts S.W. The development of enhanced arterial serotonergic hyperresponsiveness in mineralocorticoid hypertension. J. Hypertens. 1998, 16:811-822.